Bioventus Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Bioventus Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q1 2021 to Q2 2024.
  • Bioventus Inc. Retained Earnings (Accumulated Deficit) for the quarter ending June 29, 2024 was -$350M, a 13.6% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$350M -$42M -13.6% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 -$326M -$21.7M -7.11% Mar 30, 2024 10-Q 2024-05-07
Q4 2023 -$322M -$156M -94.5% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 -$315M -$182M -137% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$308M -$283M -1126% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 -$304M -$287M -1603% Apr 1, 2023 10-Q 2023-05-16
Q4 2022 -$165M -$159M -2404% Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$133M -$127M -2038% Oct 1, 2022 10-Q 2022-11-21
Q2 2022 -$25.1M -$20M -386% Jul 2, 2022 10-Q 2022-08-12
Q1 2022 -$17.9M -$16.8M -1617% Apr 2, 2022 10-Q 2022-05-11
Q4 2021 -$6.6M Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$6.24M Oct 2, 2021 10-Q 2021-11-10
Q2 2021 -$5.17M Jul 3, 2021 10-Q 2021-08-11
Q1 2021 -$1.04M Apr 3, 2021 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.